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Abstract
Background: Staphylococcus aureus, particularly methicillin-resistant S. aureus (MRSA), is an important cause of 
pyogenic skin and soft tissue infections (SSTIs). The aim of present study is to investigate the molecular characteristic of 
Staphylococcus aureus isolates isolated from the pus samples from the patients with purulent skin and soft tissue 
infections in Wenzhou, China.
Methods: Between December 2002 and June 2008, a total of 111 nonduplicate S. aureus isolates were collected from 
the pus samples of the patients with SSTIs in a teaching hospital in Wenzhou, China. All the tested isolates were 
confirmed as S. aureus using a Staph SPA agglutination kit, Gram's stain and a Vitek-60 microbiology analyzer. The 
homology among the tested isolates was determined by pulsed-field gel electrophoresis (PFGE). Multilocus sequence 
typing (MLST) was used to determine the sequence types (STs) of the selected isolates. The genotypes of SCCmec were 
determined by a multiplex PCR in the MRSA isolates. Panton-Valentine leukocidin (PVL) genes and mecA were also 
determined by another multiplex PCR.
Results: Among the 111 S. aureus isolates, 48 and 63 isolates were community-acquired and hospital-acquired 
respectively. Sixty isolates were confirmed as MRSA harboring mecA detected by PCR. A total of 32 PFGE clonal types 
were obtained by PFGE, with 10 predominant patterns (types A to J). Twenty-five different STs including ST398 and 
three novel STs were found among 51 selected isolates. The main STs were ST239, ST1018, ST59, ST7 and ST88. Of 60 
MRSA isolates, SCCmec II, III, IV and SCCmec V were found in three, 50, three and two isolates, respectively. The positive 
rates of PVL genes in overall isolates, HA-isolates, CA-isolates, MRSA isolates and MSSA isolates were 23.4% (26/111), 
20.6% (13/63), 27.1% (13/48), 21.7% (13/60) and 25.5% (13/51), respectively. Eight (33.3%, 8/24) of 24 CA-MRSA isolates 
and 5 (13.9%, 5/36) of 36 HA-MRSA isolates were positive for PVL genes. ST239-MRSA-SCCmecIII and ST1018-MRSA-
SCCmecIII clones were found to be main clones and spread between community and hospital.
Conclusion: S. aureus isolates causing SSTIs showed considerable molecular heterogeneity and harbored high 
prevalence of PVL genes. Clonal spread was responsible for the dissemination of the isolates of S. aureus associated 
with SSTIs.
Background
Infections caused by Staphylococcus aureus, especially
methicillin-resistant S. aureus (MRSA), are emerging as a
major public health problem. MRSA has been associated
with skin and soft tissue infections (SSTIs), endovascular
infections, pneumonia, septic arthritides, endocarditis,
osteomyelitis and sepsis [1]. Since the first European iso-
late of MRSA was detected in 1960s, MRSA has become a
leading cause of nosocomial infections worldwide [1,2].
In recent years, making even more complex the under-
standing of the epidemiology is the widespread dissemi-
nation of community-associated MRSA (CA-MRSA)
afflicting individuals with no apparent risk factors for
hospital acquisition and often possessing a potential viru-
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lence factor, Panton-Valentine leukocidin (PVL) [2]. The
carriage of PVL genes, pulsed-field gel electrophoresis
(PFGE), staphylococcal cassette chromosome mec (SCC-
mec) typing and multilocus sequence typing (MLST)
were performed to monitor the evolutionary process of
pandemic clones [3-6]. However, PVL genes have been
detected infrequently in hospital-acquired MRSA isolates
(HA-MRSA) in the Western Europe [5,7,8]. During the
last decade, several major pandemic clones have been
identified, including Brazilian clone, Hungarian clone,
Portuguese clone, New York/Japan clone, Pediatric clone,
Iberian clone and UK EMRSA-16 [9]. In China, the data
from previous studies showed that the widespread pre-
dominant clone among HA-MRSA isolates was the Hun-
garian clone (ST239 SCCmec III) [10,11]. However, the
epidemiology of Chinese S. aureus isolates isolated from
the patients with SSTIs is poorly documented. The aim of
this study was to investigate the epidemiology of S.
aureus  i s o l a t e s  a s s o c i a t e d  w i t h  S S T I s  b y  a  v a r i e t y  o f
molecular methods and epidemiological data in a teach-
ing hospital in Wenzhou, China.
Methods
From December 2002 to June 2008, a total of 111 non-
duplicate S. aureus isolates were collected from the pus
samples of the patients with SSTIs including lesions
requiring incision and drainage or with spontaneously
draining purulent fluid, carbuncles, furuncles, boils, cel-
lulitis with purulent drainage, chronic ulcer and deep
wounds in a teaching hospital in Wenzhou, China. The S.
aureus isolates isolated from the patients with SSTIs with
clinical signs and symptoms of infection including
increased white blood cell counts, fevers, redness, swell-
ing, and exudate, were considered for inclusion. The iso-
lates isolated from the patients without clinical signs and
symptoms of infection were considered for colonization
and exclusion. The clinical isolates were confirmed as S.
aureus using a Staph SPA agglutination kit (bioMe'rieux,
Marcy l'Etoile, France), Gram's stain and a Vitek-60
microbiology analyser (bioMe'rieu, Marcy l' Etoile,
France). The isolates, which were isolated from the
patients who had no risk factors for nosocomial acquisi-
tion and no hospitalizations or nursing home residence
within a year before hospital admission within 48 hours
after hospital admission, were considered to be commu-
nity-associated. The isolates, which were isolated from
the inpatients with no infections before hospital admis-
sion and more than 48 hours after hospital admission,
were determined as HA-isolates. All tested isolates were
digested with lysostaphin (1 mg/ml) (Sangon, China) at
37°C for 30 min. All the DNA was purified following the
instruction of the Genomic DNA Extraction kit (Sangon,
China). The DNA was stored at -20°C and prepared for
PCR detection. Chromosomal DNA was prepared from
all the isolates and cleaved with 40 U XbaI (Sangon,
China). Electrophoresis was performed on 1% agarose
gels in 0.5 M Tris/borate/EDTA buffer on a CHEF-Map-
per XA PFGE system (Bio-Rad, Hercules, CA) for 22
hours at 14°C, with run conditions of 6 V/cm, a pulse
angle of 120 degrees and pulse times from 5 to 20 sec-
onds. A λDNA ladder (Amersham Biosciences, Piscat-
away, NJ) was used as molecular mass marker and bands
were stained with ethidium bromide (0.5 μg/ml) and pho-
tographed under UV light. PFGE profiles were inter-
preted by the criteria described previously [12]. MLST
was performed as described previously and ST numbers
were assigned according to the S. aureus database http://
saureus.mlst.net/[3]. The SCCmec typing of MRSA iso-
lates was performed under the conditions as described
previously [6]. The SCCmec V isolates were further deter-
mined by the methods described by Zhang et al and Mil-
heirico et al. [6,13]. Reference strains were MRSA NCTC
10442 (SCCmec I), MRSA N315 (SCCmec II), MRSA 85/
2082 (SCCmec III), MRSA JCSC 4744 (SCCmec IV) and
MRSA HS663 (SCCmec V). The presences of the mec A
and PVL genes were determined as described previously
[5].
Ethical approval was not needed for the present
study
Results
One hundred and eleven S. aureus isolates were isolated
from the patients aged from 4 days to 80 years old with
purulent SSTIs. Among the 111 S. aureus isolates, 48 CA-
isolates were associated generally with the diseases of
purulent dermatitis, burns, pemphigus, maternal breast
abscesses, while 63 HA-isolates were mainly associated
with surgical intervention, burns or other localized infec-
tions with the risk factors as follows: the histories of prior
hospitalization in an acute-care setting, hemodialysis,
enter via-catheterization, arteriovenous shunts, tracheos-
tomy or surgery in the year preceding MRSA isolation.
And all the patients with purulent SSTIs caused by S.
aureus recovered under the treatment of antibiotic and
appropriate nursing care. Sixty isolates were confirmed as
MRSA determined by PCR for detecting mecA. Of 60
MRSA isolates, 36 and 24 isolates were hospital-associ-
ated and community-associated.
The 111 isolates were clustered into 32 PFGE clonal
types by PFGE, with 10 predominant patterns (designated
types A to J) accounting for 72 isolates. The most preva-
lent PFGE clonal type was type A (13 isolates). The iso-
lates belonging to PFGE type E, H, I and J were found
only in HA-isolates, while the isolates belonging to PFGE
type A, B, C, D, F, and G were detected not only in HA-
isolates but also in CA-isolates.
MLST was performed on representative isolates based
on PFGE type and all PVL-positive isolates. A total of 25Yao et al. BMC Infectious Diseases 2010, 10:133
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different sequence types (STs) were found among 51
selected isolates, mainly including ST239, ST1018, ST88,
ST59 and ST7 (Table. 1). Three novel STs including
ST1349, ST1357 and ST1358, were first found in the
present study. Twenty-one STs including novel ST1349
and ST1358 were found in CA-isolates, while 17 STs were
found in HA-isolates. The most dominant ST was ST239
which was found in 20 HA-isolates and four CA-isolates.
Twenty ST239 HA-isolates persisting in our hospital
from 2003 to 2008 were found among PFGE types B, E, J
and M isolates and four ST239 CA-isolates were detected
among PFGE type B isolates in 2007. ST1018 was found
to be the second common ST. Seven ST1018 CA-isolates
and six ST1018 HA-isolates were found between 2003
and 2008. The ST of six HA-isolates and four CA-isolates
was ST88. Nine of 11 ST59 isolates were HA-isolates iso-
lates. ST88 was the most common ST in the PVL-positive
isolates (7/26).
Of 60 MRSA isolates, three, 50, three and two isolates
harbored SCCmec II, SCCmec III, SCCmec IV and SCC-
mec V, respectively. The remaining two isolates were non-
typeable by the multiplex PCR method used.
T wenty-six isolates were positive for PVL genes. The
positive rates of PVL genes in overall isolates, HA-iso-
lates, CA-isolates, MRSA isolates and MSSA isolates
were 23.4% (26/111), 20.6% (13/63), 27.1% (13/48), 21.7%
(13/60) and 25.5% (13/51), respectively. The prevalence of











II I I I I VVN T
239 24 B, E, J, M 19 4 4 19
1018 13 A 10 2 7 1 9
59 11 D, H 2 0 2 2
71 0 C 2 2 3 2
88 10 G, I 6 6 4 3 3
188 6 F 1 0 4 1
54K ,  X2 2 3 2
25 3 N 2 2 3 1 1
243 3 O 2 0 2 1 1
594 3 L 3 0 2 2 1
72 2 R 1 1 0 1
366 2 S 2 0 2 2
398 2 NT 1 2 1 1
837 2 OA, OD 1 0 2 0 1
944 2 Q 1 0 1 1
1301 2 P 0 2 0
86 2 V, W 1 1 1 1
12 U 0 0 2
15 2 T 0 0 1
20 1 Y 1 0 1 1
370 1 Z 0 0 0
1019 1 OB 1 0 1 1
1349 1 OC 1 1 1 1
1357 1 OE 1 1 0 1
1358 1 OF 0 0 1
PFGE types concluded 32 types: A to Z and OA, OB, OC, OD, OE and OF; NT: non-typeableYao et al. BMC Infectious Diseases 2010, 10:133
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PVL genes among CA-MRSA isolates (33.3%, 8/24) was
higher than that among HA-MRSA isolates (13.9%, 5/36).
On the basis of MLST and SCCmec  typing, ST239-
MRSA-SCCmec III clone was found to be the most preva-
lent clone among HA-isolates (19/63), while ST1018-
MRSA- SCCmec III clone was more likely to be obtained
among CA-isolates (7/48). ST239-MRSA- SCCmec  III
and ST1018-MRSA- SCCmec  III clones were obtained
both in CA-isolates and HA-isolates. ST88-MRSA-SCC-
mec IV clone was found in three HA-isolates. The ST of
the two isolates which could not be digested with SmaI
was documented as ST398. One ST398- CA-MRSA-
SCCmec III isolate was detected from a patient with the
infection of gluteal muscles in 2002. The other ST398 iso-
late, which was detected in a patient aged 48 with the sur-
gery of renal transplantation, was HA-MSSA. Novel
ST1349, ST1357 and ST1358 were found in one PVL-
positive CA-MRSA-SCCmec III isolate, one PVL-positive
HA-MRSA-SCCmec III isolate and one CA-MSSA iso-
late, respectively.
Two MRSA isolates harbor SCCmec V were commu-
nity-associated.
Discussion
PFGE type A, B, C, D, F, G and K isolates had penetrated
both in hospital and community in specified years, indi-
cating that S. aureus isolates associated with SSTIs were
spreading between community and hospital in Wenzhou,
China. Whereas PFGE type E isolates were spread only in
hospital. Previous studies demonstrated that the most
prevalent clones in China were Brazilian/Hungarian
(ST239-MRSA- SCCmec III) and New York/Japan (ST5-
MRSA-SCCmec  II) clones and had unique geographic
distributions [10,11,14]. Similar to previous studies,
ST239-MRSA-SCCmec III clone was also found to be the
most prevalent clone among S. aureus isolates associated
with SSTIs both in community and hospital. In contrast
to previous study, only two ST5-MRSA- SCCmec II iso-
lates were found in the present study. Although ST1018-
MRSA-SCCmecIII clone was not widely reported before,
the clone was predominantly detected among CA S.
aureus isolates, ST88 was the most prevalent ST among
PVL-positive S. aureus isolates in our previous study [15].
ST88 clone was also an important clone among S. aureus
isolates causing SSTIs. We had reported the molecular
characteristic of 10 PVL-positive S. aureus isolates asso-
ciated with SSTIs from January 2005 to January 2006 [15].
The data of the present study included the six PVL-posi-
tive isolates associated with SSTIs in our previous study
[15]. Because other four PVL-positive MRSA isolates
including one ST398 isolate died, the data of these four
isolates were excluded from the present study. Histori-
cally it has been reported that HA-MRSA isolates mainly
harbor SCCmec I, II and III, whereas SCCmec IV and V
are found mainly in CA-MRSA isolates [16,17].
In contrast to previous studies, SCCmec IV was found
in HA-MRSA isolates and SCCmec III was found both in
HA- and CA-MRSA isolates, indicating that MRSA iso-
lates harboring SCCmec IV and MRSA isolates harboring
SCCmec III can spread between hospital and community.
PVL was supposed to be an important virulent factor in
CA-MRSA isolates and a strong epidemiological associa-
tion between PVL genes and successful CA-MRSA lin-
eages, especially with the disease of SSTIs [18-20]. We
also found the high prevalence of PVL genes among both
HA- and CA-isolates and that the prevalence of PVL
genes in HA-isolates was almost as high as that in CA-
isolates. However, there was higher prevalence of PVL
genes in CA-MRSA isolates than that in HA-MRSA iso-
lates. MRSA clonal type ST398 is usually associated with
the infections of animals, especially pigs [21,22]. How-
ever, human infections caused by MRSA ST398 isolates
have been reported in many countries [23,24]. PVL-posi-
tive MRSA ST398 isolates associated with human infec-
tions has been reported [15,25]. Two PVL positive S.
aureus ST398 isolates including one MRSA isolate and
one MSSA isolate were also found in the present study.
These data indicate that immediate monitoring is
required for the spread of MRSA ST398 isolates.
Conclusion
S. aureus isolates causing SSTIs showed considerable
molecular heterogeneity and harbored high prevalence of
PVL genes. Clonal spread was responsible for the dissem-
ination of the isolates of S. aureus associated with SSTIs.
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